Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from dorsaVi Limited ( (AU:DVL) ) is now available.
dorsaVi Limited has notified the market of the issue of 24 million unquoted performance rights under the ASX code DVLAG, effective 23 December 2025. The new securities, which are not quoted and are not intended to be quoted on the ASX, form part of a previously announced transaction, signalling the company’s continued use of equity-based incentives or structures that may influence future capital structure and management or employee alignment, with potential dilutionary implications for existing shareholders over time.
The most recent analyst rating on (AU:DVL) stock is a Sell with a A$0.04 price target. To see the full list of analyst forecasts on dorsaVi Limited stock, see the AU:DVL Stock Forecast page.
More about dorsaVi Limited
dorsaVi Limited is an ASX-listed company (code: DVL) that operates in the technology and medical/biomechanics space, providing sensor-based movement analysis and related solutions. Its products and services are typically used in clinical, workplace, and elite sports settings to assess human movement and assist in injury prevention, performance optimisation, and ergonomic risk management.
Average Trading Volume: 4,899,965
Technical Sentiment Signal: Hold
Current Market Cap: A$33.76M
See more insights into DVL stock on TipRanks’ Stock Analysis page.